ASMB
Income statement / Annual
Last year (2023), Assembly Biosciences, Inc.'s total revenue was $7.16 M,
and the percentage change from the previous year is not available.
In 2023, Assembly Biosciences, Inc.'s net income was -$61.23 M.
See Assembly Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$7.16 M
|
$0.00
|
$6.25 M
|
$79.11 M
|
$15.96 M
|
$14.80 M
|
$9.02 M
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$450,000.00 |
$498,000.00 |
$466,000.00 |
$101,337.00 |
$85,324.00 |
$72.74 M |
$44.23 M |
$80,251.00 |
$64,989.00 |
$0.00 |
| Gross Profit |
$6.71 M |
-$498,000.00 |
$5.79 M |
$79.00 M |
$15.88 M |
-$57.94 M |
-$35.21 M |
-$80,251.00 |
-$64,989.00 |
$0.00 |
| Gross Profit Ratio |
0.94 |
0 |
0.93 |
1 |
0.99 |
-3.91 |
-3.9 |
0 |
0 |
0 |
| Research and Development
Expenses |
$48.90 M
|
$69.98 M
|
$68.52 M
|
$106.82 M
|
$85.76 M
|
$72.74 M
|
$44.23 M
|
$33.09 M
|
$18.36 M
|
$10.72 M
|
| General & Administrative
Expenses |
$22.91 M
|
$24.13 M
|
$28.78 M
|
$37.06 M
|
$32.92 M
|
$34.80 M
|
$17.02 M
|
$12.19 M
|
$11.30 M
|
$13.24 M
|
| Selling & Marketing
Expenses |
-$450,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$22.46 M
|
$24.13 M
|
$28.78 M
|
$37.06 M
|
$32.92 M
|
$34.80 M
|
$17.02 M
|
$12.19 M
|
$11.30 M
|
$13.24 M
|
| Other Expenses |
-$48.90 M |
$0.00 |
$41.64 M |
$0.00 |
$5,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$71.36 M |
$94.11 M |
$97.30 M |
$143.88 M |
$118.68 M |
$107.54 M |
$61.25 M |
$45.28 M |
$29.66 M |
$23.96 M |
| Cost And Expenses |
$71.81 M |
$94.11 M |
$97.30 M |
$143.88 M |
$118.68 M |
$107.54 M |
$61.25 M |
$45.28 M |
$29.66 M |
$23.96 M |
| Interest Income |
$3.45 M |
$1.02 M |
$302,000.00 |
$2.62 M |
$4.30 M |
$3.08 M |
$983,209.00 |
$1.54 M |
$1.23 M |
$167,653.00 |
| Interest Expense |
$0.00 |
-$498,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$450,000.00
|
$498,000.00
|
$466,000.00
|
$691,000.00
|
$494,000.00
|
$643,000.00
|
$219,225.00
|
$80,251.00
|
$64,989.00
|
$10,974.00
|
| EBITDA |
-$64.20 M
|
-$94.11 M
|
-$49.41 M
|
-$64.09 M
|
-$102.71 M
|
-$92.09 M
|
-$51.39 M
|
-$44.06 M
|
-$29.56 M
|
-$23.95 M
|
| EBITDA Ratio |
-8.96 |
0 |
-7.9 |
-0.81 |
-6.43 |
-6.22 |
-5.7 |
0 |
0 |
0 |
| Operating Income Ratio
|
-9.02
|
0
|
-21.22
|
-0.82
|
-6.43
|
-6.26
|
-5.79
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$3.45 M
|
$1.02 M
|
$302,000.00
|
$2.62 M
|
$4.31 M
|
$3.08 M
|
-$615,128.00
|
-$1.14 M
|
-$27,033.00
|
$167,653.00
|
| Income Before Tax |
-$61.20 M |
-$93.09 M |
-$132.39 M |
-$62.15 M |
-$98.41 M |
-$89.65 M |
-$51.86 M |
-$44.88 M |
-$28.45 M |
-$23.79 M |
| Income Before Tax Ratio
|
-8.54
|
0
|
-21.17
|
-0.79
|
-6.16
|
-6.06
|
-5.75
|
0
|
0
|
0
|
| Income Tax Expense |
$33,000.00 |
-$1.02 M |
-$2.53 M |
-$2.62 M |
-$774,000.00 |
$1.10 M |
-$9.05 M |
-$617,672.00 |
-$1.20 M |
$0.00 |
| Net Income |
-$61.23 M |
-$92.07 M |
-$129.86 M |
-$59.53 M |
-$97.63 M |
-$90.75 M |
-$42.81 M |
-$44.26 M |
-$28.45 M |
-$23.79 M |
| Net Income Ratio |
-8.55 |
0 |
-20.76 |
-0.75 |
-6.12 |
-6.13 |
-4.75 |
0 |
0 |
0 |
| EPS |
-13.38 |
-22.82 |
-36 |
-20.16 |
-44.62 |
-3.98 |
-2.41 |
-2.57 |
-1.81 |
-3.4 |
| EPS Diluted |
-13.38 |
-22.82 |
-36 |
-20.16 |
-44.62 |
-3.98 |
-2.41 |
-2.57 |
-1.81 |
-3.4 |
| Weighted Average Shares
Out |
$4.58 M
|
$4.03 M
|
$3.61 M
|
$2.95 M
|
$2.19 M
|
$22.80 M
|
$17.75 M
|
$17.23 M
|
$15.70 M
|
$7.00 M
|
| Weighted Average Shares
Out Diluted |
$4.58 M
|
$4.03 M
|
$3.61 M
|
$2.95 M
|
$2.19 M
|
$22.80 M
|
$17.75 M
|
$17.23 M
|
$15.70 M
|
$7.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
